COMBINATION ENZYME FOR CYSTIC FIBROSIS
First Claim
1. A pharmaceutical preparation to treat pancreatic disorders comprising a therapeutically effective amount of digestive/pancreatic enzymes selected from the group consisting of:
- amylase, lipase, protease, chymotrypsin, trypsin, papaya, papain, and a combination thereof.
2 Assignments
0 Petitions
Accused Products
Abstract
A stable preparation of digestive/pancreatic enzymes which can be readily formed into a dosage formulation is provided as a treatment of pancreatic insufficiency in persons having cystic fibrosis. The dosage formulation can be administered either by an oral preparation including, but not limited to, a microcapsule, mini-capsule, time released capsule, sprinkle or other methodology. A further object of this invention is to provide a stabilized preparation of a combination medicant which resists degradation by light, heat, humidity or association with commonly used excipients.
171 Citations
23 Claims
-
1. A pharmaceutical preparation to treat pancreatic disorders comprising a therapeutically effective amount of digestive/pancreatic enzymes selected from the group consisting of:
- amylase, lipase, protease, chymotrypsin, trypsin, papaya, papain, and a combination thereof.
- View Dependent Claims (2, 3, 4, 5, 6, 7, 8, 9, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22)
-
10. (canceled)
-
23-27. -27. (canceled)
Specification